Premium
The Interplay Between Nonalcoholic Fatty Liver Disease and Atherosclerotic Heart Disease
Author(s) -
Patel Samarth Siddharth,
Siddiqui Mohammad Shadab
Publication year - 2019
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.30410
Subject(s) - medicine , nonalcoholic fatty liver disease , fatty liver , coronary artery disease , cardiology , dyslipidemia , fibrosis , endocrinology , disease
Nonalcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease, exists in two predominant histological subtypes: nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). NASH is the clinically aggressive variant with higher risk of fibrosis progression and mortality. The leading cause of mortality in patients with NAFLD is cardiovascular disease (CVD), and is linked to diagnosis of NASH and severity of hepatic fibrosis. This article is protected by copyright. All rights reserved.